Asia Deal Watch: Everest Licenses Asia Rights To Calliditas’ IgA Nephropathy Candidate

 
• By Ian Haydock, Jung Won Shin, Brian Yang, and Joseph Haas
  
IgA Glomerulonephritis Illustration
IgA nephropathy is far more prevalent in China than in the US or Europe
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business